Chronic kidney disease clinical trials
1,235 studies are looking for volunteers right now. Search near you to see which are close by and who can take part.
Or see all chronic kidney disease studies in TrialFinder. Live data from ClinicalTrials.gov, updated daily.
At a glance
Where the studies are
U.S. states with the most recruiting chronic kidney disease studies. A study counts once in each state where it has a site.
- California111
- New York95
- Texas95
- Florida87
- Illinois72
- Pennsylvania71
- Massachusetts68
- North Carolina65
- Ohio62
- Georgia61
- Maryland61
- Missouri58
Also in China (208), France (161), Italy (101), Germany (92), Spain (88), Canada (83), United Kingdom (82), Taiwan (65).
Types of study
Phases 1 to 4 test medicines, from first safety checks to long-term follow-up after approval. Trials of devices and programs have no phase. Observational studies give no study treatment.
- Early phase 114
- Phase 136
- Phase 1 / Phase 243
- Phase 297
- Phase 2 / Phase 36
- Phase 3108
- Phase 489
- No phase (devices, programs)428
- Observational414
Recently updated studies
Recruiting chronic kidney disease studies whose listing changed most recently. Open one in TrialFinder to check if you might qualify.
- RecruitingNo phase (devices, programs)NCT06516653
Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
Ages 18 Years – 80 Years · Long Beach, California · Sarasota, Florida +11 more · Laminate Medical Technologies
- RecruitingObservationalNCT05398783
A Natural History Study of Metabolic Sizing in Health and Disease
Ages 2 Years – 99 Years · Bethesda, Maryland · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- RecruitingObservationalNCT07680816
Metabolic and Functional Study of γδ T Cells in Critically Ill Patients
Ages 18 Years – 80 Years · Wuhan, Outside of the US · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- RecruitingPhase 1NCT06904066
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Ages 18 Years – 120 Years · Bethesda, Maryland · National Cancer Institute (NCI)
- RecruitingPhase 2NCT06585020
Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary Infection
Ages 18 Years and over · Amiens, France · Centre Hospitalier Universitaire, Amiens
- RecruitingPhase 2NCT07271186
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Ages 18 Years – 80 Years · Huntsville, Alabama · Little Rock, Arkansas +49 more · Regeneron Pharmaceuticals
- RecruitingObservationalNCT00001971
Evaluation of Patients With Liver Disease
Ages 2 Years – 100 Years · Bethesda, Maryland · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- RecruitingObservationalNCT05497518
The KidneyCARE (Community Access to Research Equity) Study
Ages 18 Years – 120 Years · Danville, Pennsylvania · Tufts Medical Center
Worth knowing
- Taking part is your choice, and you can stop at any time.
- Each study has rules about who can join. The study team checks them with you before you start.
- Talk to your doctor about whether a study is a good fit for you.